NEPHROS INC - Common Stock - $0.001 par value (NEPH)
CUSIP: 640671400
Q1 2021 13F Holders as of 31 Mar 2021
- Type / Class
- Equity / Common Stock - $0.001 par value
- Shares outstanding
- 10,630,964
- Total 13F shares
- 5,231,367
- Share change
- -50,928
- Total reported value
- $34,791,000
- Price per share
- $6.65
- Number of holders
- 17
- Value change
- -$660,885
- Number of buys
- 11
- Number of sells
- 3
Quarterly Holders Quick Answers
What is CUSIP 640671400?
CUSIP 640671400 identifies NEPH - NEPHROS INC - Common Stock - $0.001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 640671400:
Top shareholders of NEPH - NEPHROS INC - Common Stock - $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| WEXFORD CAPITAL LP |
13F
|
Company |
34%
|
3,562,246
|
$30,564,000 | — | 31 Dec 2020 | |
| Cowen Prime Services LLC |
13F
|
Company |
5.4%
|
575,077
|
$4,934,000 | — | 31 Dec 2020 | |
| Samjo Capital LLC |
13F
|
Company |
5.2%
|
550,000
|
$4,719,000 | — | 31 Dec 2020 | |
| BARD ASSOCIATES INC |
13F
|
Company |
1.9%
|
206,848
|
$1,775,000 | — | 31 Dec 2020 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
1.6%
|
167,048
|
$1,433,000 | — | 31 Dec 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.63%
|
67,439
|
$578,000 | — | 31 Dec 2020 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.52%
|
55,710
|
$478,000 | — | 31 Dec 2020 | |
| BLAIR WILLIAM & CO/IL |
13F
|
Company |
0.34%
|
36,249
|
$311,000 | — | 31 Dec 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.2%
|
21,109
|
$181,000 | — | 31 Dec 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.18%
|
19,488
|
$168,000 | — | 31 Dec 2020 | |
| ELKHORN PARTNERS LIMITED PARTNERSHIP |
13F
|
Company |
0.13%
|
14,290
|
$123,000 | — | 31 Dec 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0.04%
|
3,815
|
$33,000 | — | 31 Dec 2020 | |
| Sowell Financial Services LLC |
13F
|
Company |
0.03%
|
2,705
|
$23,000 | — | 31 Dec 2020 | |
| UBS Group AG |
13F
|
Company |
0%
|
271
|
$2,000 | — | 31 Dec 2020 |
Institutional Holders of NEPHROS INC - Common Stock - $0.001 par value (NEPH) as of Q1 2021
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2021 vs Q4 2020 Across Filers
| Investor | Q4 2020 Shares | Q1 2021 Shares | Share Diff | Share Chg % | Q4 2020 Value $ | Q1 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.